The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor
出版年份 2020 全文链接
标题
The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 35, Pages 21441-21449
出版商
Proceedings of the National Academy of Sciences
发表日期
2020-08-20
DOI
10.1073/pnas.2000516117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
- (2019) Yi Niu et al. Molecular Cancer
- The Critical Role of RNA m6A Methylation in Cancer
- (2019) Qing Lan et al. CANCER RESEARCH
- Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
- (2019) Yue Huang et al. CANCER CELL
- Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1
- (2019) Shiming Peng et al. Science Translational Medicine
- m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
- (2019) Seungwon Yang et al. Nature Communications
- HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species
- (2019) Hilary E. Nicholson et al. Science Signaling
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
- (2019) David J. Clark et al. CELL
- Synthetic lethality as an engine for cancer drug target discovery
- (2019) Alan Huang et al. NATURE REVIEWS DRUG DISCOVERY
- TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss
- (2019) Lianxin Hu et al. Cancer Discovery
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling
- (2018) Rui Su et al. CELL
- Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
- (2018) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
- (2018) Michael L Schulte et al. NATURE MEDICINE
- VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
- (2018) Jing Zhang et al. SCIENCE
- Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
- (2017) Arimichi Okazaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase
- (2017) Abhishek A. Chakraborty et al. Science Translational Medicine
- Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data
- (2017) Subarna Sinha et al. Nature Communications
- A Novel Inhibitor of the Obesity-Related Protein FTO
- (2016) Yan Qiao et al. BIOCHEMISTRY
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
- (2016) Hyejin Cho et al. NATURE
- Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma
- (2016) J M Thompson et al. ONCOGENE
- High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma
- (2015) Nicholas C. Wolff et al. Oncotarget
- High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma
- (2015) Yidong Liu et al. Scientific Reports
- Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality
- (2014) Livnat Jerby-Arnon et al. CELL
- Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
- (2014) Yue Huang et al. NUCLEIC ACIDS RESEARCH
- Exome-based analysis for RNA epigenome sequencing data
- (2013) Jia Meng et al. BIOINFORMATICS
- In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation
- (2013) Paulo A. Gameiro et al. Cell Metabolism
- SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
- (2012) M. Hassanein et al. CLINICAL CANCER RESEARCH
- Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
- (2012) Baoen Chen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Treatment selection in metastatic renal cell carcinoma: expert consensus
- (2012) Bernard Escudier et al. Nature Reviews Clinical Oncology
- New Insights into the Biology of Renal Cell Carcinoma
- (2011) Lianjie Li et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
- (2011) Guifang Jia et al. Nature Chemical Biology
- Harnessing synthetic lethal interactions in anticancer drug discovery
- (2011) Denise A. Chan et al. NATURE REVIEWS DRUG DISCOVERY
- Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
- (2009) Paul Nicklin et al. CELL
- Metastatic Renal Cell Carcinoma: Many Treatment Options, One Patient
- (2009) Brian I. Rini JOURNAL OF CLINICAL ONCOLOGY
- A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces Autophagy
- (2008) Sandra Turcotte et al. CANCER CELL
- The role of hypoxia-inducible factors in tumorigenesis
- (2008) E B Rankin et al. CELL DEATH AND DIFFERENTIATION
- The von Hippel-Lindau Tumor Suppressor Protein and Egl-9-Type Proline Hydroxylases Regulate the Large Subunit of RNA Polymerase II in Response to Oxidative Stress
- (2008) O. Mikhaylova et al. MOLECULAR AND CELLULAR BIOLOGY
- Boolean implication networks derived from large scale, whole genome microarray datasets
- (2008) Debashis Sahoo et al. GENOME BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now